Meeting
2023 ASCO Annual Meeting
Progress report of a cross-organ and biomarker-based platform study: BELIEVE trial NCCH1901.
Authors
Yayoi Ando
National Cancer Center Hospital, Chuo-Ku, Japan
Yayoi Ando , Tatsunori Shimoi , Kuniko Sunami , Natsuko Tsuda Okita , Mikio Mori , Taro Shibata , Kenichi Nakamura , Noboru Yamamoto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Care Delivery and Regulatory Policy
Track
Care Delivery and Quality Care
Sub Track
Clinical Research Design
Clinical Trial Registration Number
jRCTs031190104
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr TPS1611)
DOI
10.1200/JCO.2023.41.16_suppl.TPS1611
Abstract #
TPS1611
Poster Bd #
203b
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Genomic landscape of acquired resistance to targeted therapies in metastatic colorectal cancer (mCRC).
First Author: Emily Harrold
Poster
2016 ASCO Annual Meeting
DNA-based genomic profiling for classification of tissue of origin for patients with carcinoma of unknown primary site.
First Author: Lee A Albacker
Poster
2016 Gastrointestinal Cancers Symposium
Genomic profiling and efficacy of anti-EGFR therapy in appendiceal adenocarcinoma.
First Author: Maria Ignez Freitas Melro Braghiroli
Poster
2024 ASCO Annual Meeting
A multicohort platform trial to improve drug access for pediatric cancer patients in Japan: The PARTNER trial (NCCH2220).
First Author: Bunpei Miyazaki